I am invested in KIWA Biotechs for secveral years meanwhile, highlights are in my opinion:
Revenues increased from 17.000.000 $ in 2017 to approx. 31.000.000 $ in 2018. Earning per share is 0.04 $ in 2018.
Forecast for 2019 is + 40.000.000 $ in revenues and Earning per share: 0.1 $
Very low market capitalization of around 15.000.000 $ at these levels. Very thin free float of approx. 6.000.000
Company is successfully working in microbial bio fertilizer (there is huge difference between “normal” bio fertilizers and more complex microbial bio fertilizers) market, which is strongly supported by Chinese government. Government intends to have zero growth in chemical fertilizers, but strong growth in microbial bio fertilizers instead till year 2020.
KIWA has strong cooperation in terms of research with various reputable universities.
KIWA is the only “private” (not state-owned) company in the field of microbial bio fertilizers, which was own labarotories for research.
KIWA is holding many key patents for microbial bio fertilizers and is market leader in China for MICROBIAL bio fertilizers.
KIWA Biotechs has settled down their headquarter in Yangling free trade zone last year. This was rewarded with some financial compensation by the Yangling government.
KIWA has established the “Trinity Agricultural Marketing Model” (farmers buy KIWA’ fertilizers, farmers receive insurance protection against the risks during fruits/vegetables growth, KIWA assists farmers in selling their fruits/vegetables) in one of the “Yangling Demonstration Planting Base”. KIWA is the only company, which is offering the “Trinity Agricultural Marketing Model” so far. And there are 300 YANGLING DEMONSTRATION PLANTING BASES in China with a total of 4.4 million hectares and an annually demand for microbial bio fertilizers of 7.8 billion USD.
Recently, KIWA has won the bid for building a modern aquacultural Park in Guangdong province. This is their successful admittance to the aquacultural market, which has a size of 12.3 billion USD in China.
